CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 62 enrolled
Drug / intervention
Flunarizine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02639598
NCT02639598Phase 4Completed
CompareCT.gov

Flunarizine Versus Topiramate for Chronic Migraine Prophylaxis

Taipei Veterans General Hospital, Taiwan·interventional·Posted Dec 24, 2015·Updated Dec 24, 2015

In Brief

A Phase 4 clinical trial evaluating Flunarizine and Topiramate for Chronic Migraine. Completed, enrolled 62 participants.

Detailed Summary

Chronic migraine (CM) is a prevalent and devastating disorder with limited therapeutic options. This study explored the efficacy of 10 mg/day flunarizine for CM prophylaxis as compared with 50 mg/day topiramate.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Migraine
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedDec 24, 2015
Enrollment StartJun 1, 2012
Primary CompletionDec 1, 2014
Study CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 10.5 years ago

Interventions

Flunarizinedrug

as in "arm descriptions"

Topiramatedrug

as in "arm descriptions"